What question did this study set out to answer?

This study aims to identify baseline OCT biomarkers that can predict the development of macular atrophy and fibrosis in eyes with neovascular AMD.

June 4, 2026Ophthalmology ScienceOpen Access

Baseline OCT Biomarkers Associated with the 2-year Development of Macular Atrophy or Fibrosis in Neovascular AMD

View Full Paper

Ask AI

Bookmark

Authors

COChiara OlivieriCTO Hospital GPGiacomo PerinCTO Hospital XZXuenan ZhuangSun Yat-sen University

Discussion

Member takes

Implication

Retrospective cohort study evaluates baseline structural OCT biomarkers predicting macular complications in eyes with neovascular AMD, indicating critical assessment for outcomes.

Key Points

This study aims to identify baseline OCT biomarkers that can predict the development of macular atrophy and fibrosis in eyes with neovascular AMD.
Retrospective cohort study involving 89 treatment-naïve eyes with exudative neovascular AMD.
Baseline structural OCT scans evaluated for morphological features by two masked graders.
Cox regression models analyzed to determine predictors of macular atrophy and fibrosis over 24 months.
31.5% of eyes developed macular atrophy (HR 6.07; 95% CI 2.23-16.48) associated with baseline IRF.
Type 3 MNV was linked to macular atrophy with HR 4.38 (95% CI 1.63-11.73), while type 1 MNV was protective (HR 0.23; 95% CI 0.09-0.61).
Type 2 MNV emerged as a strong predictor for macular fibrosis (HR 7.28; 95% CI 1.51-35.10).

Cite This Study

Olivieri et al. (2026) studied this question.

synapsesocial.com/papers/6a211591d499ed480b16eacd https://doi.org/10.1016/j.xops.2026.101268

View Full Paper

Ask AI

Bookmark

June 4, 2026Ophthalmology ScienceOpen Access

Baseline OCT Biomarkers Associated with the 2-year Development of Macular Atrophy or Fibrosis in Neovascular AMD

View Full Paper

Ask AI

Bookmark

Authors

COChiara OlivieriCTO Hospital GPGiacomo PerinCTO Hospital XZXuenan ZhuangSun Yat-sen University

Discussion

Member takes

Implication

Retrospective cohort study evaluates baseline structural OCT biomarkers predicting macular complications in eyes with neovascular AMD, indicating critical assessment for outcomes.

Key Points

This study aims to identify baseline OCT biomarkers that can predict the development of macular atrophy and fibrosis in eyes with neovascular AMD.
Retrospective cohort study involving 89 treatment-naïve eyes with exudative neovascular AMD.
Baseline structural OCT scans evaluated for morphological features by two masked graders.
Cox regression models analyzed to determine predictors of macular atrophy and fibrosis over 24 months.
31.5% of eyes developed macular atrophy (HR 6.07; 95% CI 2.23-16.48) associated with baseline IRF.
Type 3 MNV was linked to macular atrophy with HR 4.38 (95% CI 1.63-11.73), while type 1 MNV was protective (HR 0.23; 95% CI 0.09-0.61).
Type 2 MNV emerged as a strong predictor for macular fibrosis (HR 7.28; 95% CI 1.51-35.10).

Cite This Study

Olivieri et al. (2026) studied this question.

synapsesocial.com/papers/6a211591d499ed480b16eacd https://doi.org/10.1016/j.xops.2026.101268

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark